SPY389.63+0.17 0.04%
DIA312.42-0.01 0.00%
IXIC11,354.62-33.88 -0.30%

BRIEF-Abbvie Says Triple Combination Drug For Cystic Fibrosis Fails To Meet Co's Criteria

reuters.com · 04/29/2022 09:36
BRIEF-Abbvie Says Triple Combination Drug For Cystic Fibrosis Fails To Meet Co's Criteria

- Abbvie Inc ABBV:

  • ABBVIE SAYS ITS TRIPLE COMBINATION DRUG FOR CYSTIC FIBROSIS FAILED TO MEET CO'S CRITERIA FOR DEVELOPING IT FURTHER - CONF CALL


Further company coverage: ABBV


((Reuters.Briefs@thomsonreuters.com;))